Today's top medical abstracts
Rheumatology
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?

Home
General Rheumatology
For Practicing
Rheumatologists
Conferences
Jobs
Newsletters
My Library
Topics in
Rheumatology
        Amyloidosis
        Autoimmune/Heritable
        Basic Science/Genetics
        Bone Metabolism
        Chr Fatigue/Fibromyalgia
        Clinical Pharmacology
        Connective Tissue Dz
        Diagnostics/Radiology
        Economics of Medicine
        Gout and Hyperuricemia
        Infectious Arthritis
        Osteoarthritis
        Other Arthritis
        Pediatric Rheumatology
        Popular Press
        Rheumatoid Arthritis
        Spondylarthropathies
        Systemic Lupus (SLE)
        Vasculitic Syndromes
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
 
Sponsor
For Practicing Rheumatologists
Today's Rheumatology News: Pycnogenol Effective In OA Patients
D Scott Cunningham MD, PhD, MDLinx Rheumatology
Today's Rheumatology News: FDA Approves Actemra
D Scott Cunningham MD, PhD, MDLinx Rheumatology
From the Editors: New Clinical-Only Option for MDLinx!
Stephen Smith, MDLinx
  See all
Article Summary

Click the title below to leave the MDLinx Network and go to the Journal's Website
Vitamin D deficiency in patients with active systemic lupus erythematosus
Osteoporosis International, 07/09/08
Print     Email This Article     Save in My Library   Free Abstract
Borba VZC et al. – This study reports that systemic lupus erythematosus (SLE) patients demonstrate changes in bone remodeling strongly related to disease activity. A high prevalence of 25OHD deficiency was observed in these patients, indicating the need for vitamin D replacement.

Methods
  • Study to investigate effects of SLE disease activity on bone metabolism, their relation to inflammatory cytokines and vitamin D levels
  • 36 SLE pts were classified according to SLEDAI in high activity or in minimal activity, and were compared with normal controls
  • Serum calcium, phosphorus, parathyroid and sex hormones, bone remodeling markers, IL-6, sIL-6R, IL-1, TNF-α 25OHD, and 1,25-dihydroxyvitamin D3 were measured, plus BMD

Results
  • All cytokines were higher in SLE groups
  • IL-6 could differentiate SLE pts from controls
  • In group I, 25OHD levels were lower which was related to the SLEDAI
  • 25OHD level was associated with SLEDAI, osteocalcin and bone-specific alkaline phosphatase
  • The SLEDAI score was positively correlated with all measured cytokines and especially TNF

 

--- BASIC SCIENCE/GENETICS TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email



 

Sponsor
--- SYSTEMIC LUPUS (SLE) TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email



Read a Different Specialty
Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pediatrics
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology
Profession Index
Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2008 MDLinx, Inc.